Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve

<div>Bar graph of the KEGG pathway analysis of DEPs in the KLP-treated group vs. the DOR group. The bar length shows the number of all DEPs associated with the GO and KEGG terms.</div>

Evidence-Based Complementary and Alternative Medicine

fig6

Figure 6

Figure 6: Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 

Figure 6 | Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 